These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21212100)

  • 1. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.
    Ricciardi S; Boggio EM; Grosso S; Lonetti G; Forlani G; Stefanelli G; Calcagno E; Morello N; Landsberger N; Biffo S; Pizzorusso T; Giustetto M; Broccoli V
    Hum Mol Genet; 2011 Mar; 20(6):1182-96. PubMed ID: 21212100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
    Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
    Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel function of MeCP2 in the pathophysiology of Rett syndrome: Regulation of mTOR signaling mediated by MeCP2-dependent microRNA processing].
    Tsujimura K; Nakashima K
    Seikagaku; 2017 Feb; 89(1):51-61. PubMed ID: 29624958
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
    Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
    BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
    Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
    Mol Autism; 2017; 8():56. PubMed ID: 29090078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
    Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
    Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
    Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
    Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeCP2 Affects Skeletal Muscle Growth and Morphology through Non Cell-Autonomous Mechanisms.
    Conti V; Gandaglia A; Galli F; Tirone M; Bellini E; Campana L; Kilstrup-Nielsen C; Rovere-Querini P; Brunelli S; Landsberger N
    PLoS One; 2015; 10(6):e0130183. PubMed ID: 26098633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
    Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological reactivation of inactive X-linked
    Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.
    Li Y; Wang H; Muffat J; Cheng AW; Orlando DA; Lovén J; Kwok SM; Feldman DA; Bateup HS; Gao Q; Hockemeyer D; Mitalipova M; Lewis CA; Vander Heiden MG; Sur M; Young RA; Jaenisch R
    Cell Stem Cell; 2013 Oct; 13(4):446-58. PubMed ID: 24094325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring Wnt6 signaling ameliorates behavioral deficits in MeCP2 T158A mouse model of Rett syndrome.
    Hsu WL; Ma YL; Liu YC; Tai DJC; Lee EHY
    Sci Rep; 2020 Jan; 10(1):1074. PubMed ID: 31974426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
    Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
    OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Gsk3b Reduces Nfkb1 Signaling and Rescues Synaptic Activity to Improve the Rett Syndrome Phenotype in Mecp2-Knockout Mice.
    Jorge-Torres OC; Szczesna K; Roa L; Casal C; Gonzalez-Somermeyer L; Soler M; Velasco CD; Martínez-San Segundo P; Petazzi P; Sáez MA; Delgado-Morales R; Fourcade S; Pujol A; Huertas D; Llobet A; Guil S; Esteller M
    Cell Rep; 2018 May; 23(6):1665-1677. PubMed ID: 29742424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of
    Morello N; Schina R; Pilotto F; Phillips M; Melani R; Plicato O; Pizzorusso T; Pozzo-Miller L; Giustetto M
    eNeuro; 2018; 5(5):. PubMed ID: 30255129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.